However, to promote cancer activity, they also target different genes including C/EBPβ, FOXO1, NFI-A, STAT5A, ARTN, FBXW7, and SEPT6 (for miR-223) [29–33] and FUS1, RhoC, PTEN, CDKN1A, TGFβR2, and NRF2 (for miR-93) [34–38]. The gene discussed is ARTN; the disease is cancer.